Myriad Genetics Inc (NASDAQ:MYGN)

32.05
Delayed Data
As of Apr 17
 -0.95 / -2.88%
Today’s Change
26.05
Today|||52-Week Range
50.44
+10.25%
Year-to-Date

Today’s Trading

Previous close33.00
Today’s open33.10
Day’s range31.63 - 33.10
Volume753,079
Average volume (3 months)917,065
Market cap$2.4B
Data as of 4:00pm ET, 04/17/2019

Growth & Valuation

Earnings growth (last year)+490.63%
Earnings growth (this year)+42.59%
Earnings growth (next 5 years)+14.90%
Revenue growth (last year)+0.16%
P/E ratio106.8
Price/Sales3.48
Price/Book2.39

Competitors

 Today’s
change
Today’s
% change
QDELQuidel Corp-3.76-5.91%
--Quidel Corp-0.74-1.32%
NEOGNeogen Corp-1.48-2.61%
IMMUImmunomedics Inc-0.84-4.80%
Data as of 4:00pm ET, 04/17/2019

Financials

Next reporting dateMay 9, 2019
EPS forecast (this quarter)$0.43
Annual revenue (last year)$772.6M
Annual profit (last year)$131.1M
Net profit margin16.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts